Agenus Inc (AGEN): R&D Expense
$79.34M
Year ended 2025-12-31
$57.69M
Trailing 12 months to 2026-06-30
-24.8%
3-year compound annual growth
-11.1%
5-year compound annual growth
+1.2%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $79.34M | -49.0% | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | $155.53M | -33.7% | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | $234.57M | +25.6% | 2026-03-16, From 2023-01-01 |
| 2022-12-31 | $186.69M | +4.5% | 2025-03-17, From 2022-01-01 |
| 2021-12-31 | $178.61M | +25.2% | 2024-03-14, From 2021-01-01 |
| 2020-12-31 | $142.62M | -15.3% | 2023-03-16, From 2020-01-01 |
| 2019-12-31 | $168.34M | +35.1% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $124.60M | +7.3% | 2021-03-16, From 2018-01-01 |
| 2017-12-31 | $116.12M | +22.3% | 2020-03-16, From 2017-01-01 |
| 2016-12-31 | $94.97M | +34.8% | 2019-03-18, From 2016-01-01 |
| 2015-12-31 | $70.44M | +215.2% | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | $22.35M | +71.8% | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | $13.01M | +23.1% | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | $10.56M | -4.2% | 2015-03-16, From 2012-01-01 |
| 2011-12-31 | $11.02M | -14.4% | 2014-03-07, From 2011-01-01 |
| 2010-12-31 | $12.88M | -23.8% | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | $16.90M | n/a | 2012-03-06, From 2009-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Agenus Inc (AGEN) | 2025-12-31 | $79.34M | -49.0% |
| ImmunityBio, Inc. (IBRX) | 2024-12-31 | $190.14M | -18.2% |
| Century Therapeutics, Inc. (IPSC) | 2025-12-31 | $95.67M | -10.8% |
| Atara Biotherapeutics, Inc. (ATRA) | 2025-12-31 | $37.45M | -75.3% |
| Monte Rosa Therapeutics, Inc. (GLUE) | 2025-12-31 | $141.50M | +16.4% |
| Sutro Biopharma, Inc. (STRO) | 2025-12-31 | $166.42M | -34.0% |
| Beam Therapeutics Inc. (BEAM) | 2025-12-31 | $409.62M | +11.4% |
| 4D Molecular Therapeutics, Inc. (FDMT) | 2025-12-31 | $195.70M | +38.5% |
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | $129.62M | +8.5% |
Compare AGEN, IBRX, IPSC, ATRA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗